• EnglishEnglish
    • Deutsch Deutsch
    • Italiano Italiano
    • Français Français
    • 日本語 日本語
    • 한국어 한국어

CISEMA - China Zertifizierung, Einkauf und Qualitätssicherung

  • Services
    • NMPA Registration – Medical Devices and IVDs
    • NMPA Registration & DMF – Pharmaceuticals
    • NMPA Registration – Cosmetics
    • NMPA Registration – Health Food
    • CML (China Manufacture Licence) – Pressure vessels
    • CCC (China Compulsory Certification) – Industrial and consumer goods
    • Others
      • Sourcing and Quality Control
      • Logistics and Customs Support
      • Sales Support
  • Events
    • Trade Fairs & Conferences
    • Seminars
    • Webinars
  • News & Knowledge
    • Regulatory News
      • Medical Devices and IVDs
      • Cosmetics
      • Pharmaceuticals & DMF
      • CCC
      • Pressure Vessels
    • Whitepapers
    • FAQ – NMPA Registration – Medical Devices and IVDs
    • Newsletter Sign Up
    • Others
      • Publications
      • Online Shop
  • About us
    • Partners
    • Company Profile
    • Testimonials
  • Locations
  • Newsletter Sign Up
Contact
  • Home
  • News
  • News
  • NMPA Registration in China
  • Cosmetics
  • China radio frequency beauty devices regulated as Class III medical devices from April 1, 2024, onwards

China radio frequency beauty devices regulated as Class III medical devices from April 1, 2024, onwards

China radio frequency beauty devices
Friday, 28 April 2023 / Published in Cosmetics, Medical Device, News, NMPA Registration in China

China radio frequency beauty devices regulated as Class III medical devices from April 1, 2024, onwards

China radio frequency beauty devices have new technical review guidelines issued (No.8-2023) by the Center for Medical Device Evaluation (CMDE) under the National Medical Products Administration (NMPA) on April 12, 2023. The guidelines provide strict regulations for radio frequency (RF) beauty devices, in order to ensure that these products are safe and effective for use in beauty clinics, spas, homes, etc.

Manufacturers of radio frequency beauty devices must comply with the new technical review guidelines starting from April 1, 2024. This date marks the beginning of the transition period for the new regulations, which require manufacturers to perform feasibility studies and submit pre-market regulatory submissions demonstrating product safety and effectiveness, among other things.

Scope

Back in March 2022, the medical device classification catalogue was amended by the NMPA to reclassify class II radiofrequency devices for treatment of the skin surface under the classification code of 09-07-02 to class III radiofrequency devices for non-ablative treatments. It was already required that manufacturers, importers, and sellers of radiofrequency therapy equipment must obtain the respective medical device registration certificates in compliance with the new regulations from April 1, 2024, onwards. However, there were different views in the industry at that time as to whether home-use radio frequency beauty devices would be included whilst some believed that only RF beauty devices with medical indications would fall under the scope as medical devices.

The new guidelines clarified that radio frequency beauty equipment would cover both vertical or benchtop (large) radio frequency beauty equipment, as well as handheld (small) equipment:

  • Vertical or benchtop (large) radio frequency beauty equipment should be limited for use in a professional medical institution environment (including medical beauty clinics)
  • Handheld (small) equipment can be used in a home environment.

This would imply that home-use RF beauty devices would also be required to register as class III medical devices in China upon the date of implementation of the new guidelines.

Specification

In addition, the new guidelines addressed the electrical energy frequency specifications for RF beauty devices to produce a thermal effect on human tissues in general:

  • Above 200kHz for radio frequency current
  • 13.56 or 40.68 MHz for electric fields

The intended use of RF beauty devices have also been specified to treat skin laxity, reduce skin wrinkles, shrink pores, tighten/lifting skin tissue, or treat acne, scarring, or reduce fat (fat softening or breakdown), etc.

These guidelines do not apply to high frequency surgical devices used in the field of aesthetic surgery. Although these products also use high-frequency currents on the body, they achieve a cutting and coagulation effect, which is not the same as the mechanism of action of the RF devices described in this guideline.

Further information

Read the full CDME announcement on the new technical review guidelines for radio frequency beauty devices.

Cisema can help you comply with these new guidelines. Let us know if you would like to learn more about our registration, quality management, clinical research and testing services for medical devices and IVDs in China.

GET IN TOUCH

🌐 Send us your enquiry
📚 Request our whitepapers
📣 Sign up for our newsletter

What you can read next

china clinical trials drugs GMP
China Clinical Trials for Drugs GMP appendix has been released
Extension of Exemption List for Medical Devices and IVDs soon
China medical device classification
China medical device classification results released for July to September 2022

Search

Categories

  • Fairs & Events
  • News
    • CCC
    • CEL
    • CML, SELO
    • Medical Devices Listing in Hong Kong
    • NMPA Registration in China
      • Cosmetics
      • Health Food
      • Medical Device
      • Pharmaceuticals & DMF
    • RoHS
    • Voluntary Product Certification
  • Publications
  • Seminars
  • Uncategorized
  • Webinars

Recent Posts

  • Submission of safety information for cosmetics ingredients

    Submission of safety information for cosmetics raw materials – Draft guidelines issued

    Submission of safety information for cosmetics ...
  • avoid animal testing in Chinaweb-2023

    How to avoid animal testing in China for cosmetics | Cisema Webinar

    China’s beauty and cosmetic market has be...
  • guidelines for medical devices registration

    Guidelines for medical devices registration in China – New development plans in 2023

    Guidelines for medical devices registration in ...
  • China DMF of API

    China DMF of API, Excipient & Packaging Materials: Market & Regulatory | Cisema Webinar

    “China DMF of API, Excipient & Packag...
  • pre-phase III drug clinical trial meeting guidelines

    Pre-phase III drug clinical trial meeting guidelines released

    Pre-phase III drug clinical trial meeting guide...

Archive

Cisema

With twelve locations and over ninety highly qualified employees, Cisema can offer you optimal support in China.

Services

  • Certification
  • Sourcing and Quality Control
  • Logistics and Customs Support
  • Sales Support

Dialogue

  • Contact us
  • Newsletter Signup
  • Events
  • News & Knowledge
  • Partners

Company

  • GTC
  • Privacy Statement
  • Legal Notice
  • About us
  • Locations
  • GET SOCIAL

© 2021 Cisema. All rights reserved.

TOP